Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Schlessinger

Showing results (691-700 of 1,351) with videos related to

Pageof 136
Sort By:
Cytogenetics and Cell Genetics|January 1, 1994
Report and abstracts of the Fifth International Workshop on Human X Chromosome Mapping 1994. Heidelberg, Germany, April 24-27, 1994H F Willard, F Cremers, J L Mandel, et al.
Nature Communications|May 16, 2013
Constitutively active Foxo3 in oocytes preserves ovarian reserve in miceEmanuele Pelosi, Shakib Omari, Marc Michel, et al.
Genes to Cells : Devoted to Molecular & Cellular Mechanisms|August 25, 2015
Structural analysis of the mechanism of phosphorylation of a critical autoregulatory tyrosine residue in FGFR1 kinase domainYoshihiro Kobashigawa, Shinjiro Amano, Mariko Yokogawa, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 8, 2014
The docking protein FRS2α is a critical regulator of VEGF receptors signalingPei-Yu Chen, Lingfeng Qin, Zhen W Zhuang, et al.
Tetrahedron Letters|April 26, 2011
Aryl Extensions of Thienopyrimidinones as Fibroblast Growth Factor Receptor 1 Kinase InhibitorsAnil R Ekkati, Valsan Madiyan, Krishna P Ravindranathan, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|April 1, 1990
Generation of recombinant cytoplasmic domain of epidermal growth factor receptor with intrinsic protein tyrosine kinase activityC Y Hsu, M Mohammadi, M Nathan, et al.
Journal of Drugs in Dermatology : JDD|June 23, 2009
The efficacy and safety of a new U.S. Botulinum toxin type A in the retreatment of glabellar lines following open-label treatmentMark G Rubin, Jeffrey Dover, Richard G Glogau, et al.
Molecular and Cellular Biology|June 1, 1990
Epidermal growth factor receptor cytoplasmic domain mutations trigger ligand-independent transformationS Massoglia, A Gray, T J Dull, et al.
Biochemical and Biophysical Research Communications|February 24, 1997
Expression and cloning of the human X-linked hypophosphatemia gene cDNAM Grieff, S Mumm, P Waeltz, et al.
The Journal of Investigative Dermatology|March 14, 2017
miRNAs Are Required for Postinduction Stage Sweat Gland DevelopmentChang-Yi Cui, Yulan Piao, Dean P Campbell, et al.
Pageof 136

Showing results (691-700 of 1,351) with videos related to

Sort By:
Pageof 136
Cytogenetics and Cell Genetics|January 1, 1994
Report and abstracts of the Fifth International Workshop on Human X Chromosome Mapping 1994. Heidelberg, Germany, April 24-27, 1994H F Willard, F Cremers, J L Mandel, et al.
Nature Communications|May 16, 2013
Constitutively active Foxo3 in oocytes preserves ovarian reserve in miceEmanuele Pelosi, Shakib Omari, Marc Michel, et al.
Genes to Cells : Devoted to Molecular & Cellular Mechanisms|August 25, 2015
Structural analysis of the mechanism of phosphorylation of a critical autoregulatory tyrosine residue in FGFR1 kinase domainYoshihiro Kobashigawa, Shinjiro Amano, Mariko Yokogawa, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 8, 2014
The docking protein FRS2α is a critical regulator of VEGF receptors signalingPei-Yu Chen, Lingfeng Qin, Zhen W Zhuang, et al.
Tetrahedron Letters|April 26, 2011
Aryl Extensions of Thienopyrimidinones as Fibroblast Growth Factor Receptor 1 Kinase InhibitorsAnil R Ekkati, Valsan Madiyan, Krishna P Ravindranathan, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|April 1, 1990
Generation of recombinant cytoplasmic domain of epidermal growth factor receptor with intrinsic protein tyrosine kinase activityC Y Hsu, M Mohammadi, M Nathan, et al.
Journal of Drugs in Dermatology : JDD|June 23, 2009
The efficacy and safety of a new U.S. Botulinum toxin type A in the retreatment of glabellar lines following open-label treatmentMark G Rubin, Jeffrey Dover, Richard G Glogau, et al.
Molecular and Cellular Biology|June 1, 1990
Epidermal growth factor receptor cytoplasmic domain mutations trigger ligand-independent transformationS Massoglia, A Gray, T J Dull, et al.
Biochemical and Biophysical Research Communications|February 24, 1997
Expression and cloning of the human X-linked hypophosphatemia gene cDNAM Grieff, S Mumm, P Waeltz, et al.
The Journal of Investigative Dermatology|March 14, 2017
miRNAs Are Required for Postinduction Stage Sweat Gland DevelopmentChang-Yi Cui, Yulan Piao, Dean P Campbell, et al.
Pageof 136